SAN FRANCISCO: GCI Group senior vice-president Paul Laland, who
founded and has led the firm's global biotech practice since 1999, has
left to join gene therapy company Deltagen as vice-president of
communications. Laland confirmed that two senior vice-presidents from
the San Francisco biotech team, Rick Roose and Nina Ferrari, will take
over his previous responsibilities.